Status:

RECRUITING

Development of a Recovery Oriented Treatment for Post-Acute Suicidal Episode (PASE) Veterans

Lead Sponsor:

VA Office of Research and Development

Conditions:

Suicide

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Mental health care for Veterans with suicidal symptoms is of paramount import to the VA. Unfortunately, VA suicide reports show suicide rates increasing, suggesting a need for enhancing current VA sui...

Detailed Description

Research Design and Methods Phase 1 CI-CT has not, to date, been used for the PASE Veteran population. To optimize CI-CT's effectiveness for a PASE population and continue to align it as closely as ...

Eligibility Criteria

Inclusion

  • suicide attempt, or creation of a suicide plan with intent or preparatory behavior, within the past year, as assessed using the Columbia Suicide Severity Rating Scale (CSSRS) - to provide this information, in addition to the standard lifetime/3 months categories in the CSSRS a 1 year category will be added
  • participation in mental health services at the JJPVA
  • sufficient clinical stability and readiness to participate in a group therapy as deemed by a mental health treatment provider
  • sufficient medical stability as deemed by a medical provider
  • Veteran of US Military
  • resides in NYC region

Exclusion

  • active alcohol or opiate dependence requiring medically supervised withdrawal
  • imminent risk of suicidal or homicidal behavior
  • acute suicidal episode within past week
  • current acute suicidal symptoms (based on scores of the BSI and SBQ-R - see above)
  • inability to perform CI-CT treatment tasks based on their performance on a sample reading and writing task from the CI-CT manual (given during screening), operationalized as an ability to read the sample material, understand the instructions, and write a response connected with the material and in line with the writing instructions
  • unable to speak English
  • lack of capacity to consent
  • unable or unwilling to provide at least one contact for emergency purposes
  • unable to attend outpatient group treatment program
  • participation in another intervention RCT
  • insufficient interpersonal functioning to function appropriately within the group assessed through a consultation with the referrer and the Veterans' mental health provider about their interpersonal functioning and ability to tolerate group therapy, and a chart review searching for disruptive behavior in group therapy

Key Trial Info

Start Date :

February 22 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 25 2026

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT04731519

Start Date

February 22 2022

End Date

April 25 2026

Last Update

December 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

James J. Peters VA Medical Center, Bronx, NY

The Bronx, New York, United States, 10468-3904